Secondary glaucoma in patients with familial exudative vitreoretinopathy (FEVR)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20221003007

Enrollment

Registered

2022-10-03

Start date

2021-07-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with secondary glaucoma and familial exudative vitreoretinopathy (FEVR) familial exudative vitreoretinopathy FEVR Secondary glaucoma

Interventions

Patients who diagnosed both glaucoma and familial exudative vitreoretinopathy (FEVR)

Diagnostic

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who diagnosed both glaucoma and familial exudative vitreoretinopathy (FEVR) from Faculty of medicine, Siriraj Hospital and Queen Sirikit National Institute of Child Health

Exclusion criteria

Exclusion criteria: Patients who have inconclusive diagnosis

Design outcomes

Primary

Measure	Time frame
clinical characteristics, disease progression, management and outcome since diagnosed of FEVR and glaucoma clinical characteristics, disease progression, management and outcome	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactAssist.Prof.Sakaorat Petchyim

Faculty of Medicine Siriraj Hospital, Mahidol University

sakaoratpoy012@gmail.com024198037

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026